Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 1 , ISSUE 2 ( April-June, 2007 ) > List of Articles

RESEARCH ARTICLE

Premature Ovarian Failure

Francisco Raga, Fernando Bonilla-Musoles, Newton G Osborne, Luiz E Machado, Francisco Bonilla

Citation Information : Raga F, Bonilla-Musoles F, Osborne NG, Machado LE, Bonilla F. Premature Ovarian Failure. Donald School J Ultrasound Obstet Gynecol 2007; 1 (2):64-79.

DOI: 10.5005/jp-journals-10009-1100

License: CC BY-NC 4.0

Published Online: 00-06-2007

Copyright Statement:  Copyright © 2007; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Using autoradiography, transmission and raster electron microscopy, this review shows how oocytes disappear in human ovaries.

Clinical, hormonal and ultrasound (using 3D, vocal and inverse mode) parameters used in the diagnosis of early ovarian aging are described on the light of the most recent knowledge.


PDF Share
  1. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Human Reprod Update 2001;7:581-90.
  2. Failed in vitro fertilization of human oocytes: a cytogenetic analysis. Fertil Steril 1991;56:290-5.
  3. In vitro fertilization plus preimplantation genetic diagnosis in patients with recurrent miscarriage: an analysis of chromosome abnormalities in human preimplantation embryos. Fertil Steril 1999;71:1033-9.
  4. Age-related decline in female fertility is not due to diminishing capacity of the uterus to sustain embryo implantation. Fertil Steril 1994;61:997-1001.
  5. Embriologia y anatomia del ovario. Rev Esp Obstet Ginecol 1974a;31:675-714.
  6. Quantitative morphological investigations of the follicular system in women. Variations at different ages. Acta Anat 1952;14:108-23.
  7. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc London Biol J 1963;158:417-33.
  8. How do oocytes disappear? Arch Gynaekol 1974b;218:233-41.
  9. Age and infertility. Science 1986;233:1389-94.
  10. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Human Reprod 1992;7:1342-6.
  11. Prevention of gonadal damage during cytotoxic therapy. Ann Med 1997;29:199-206.
  12. Regulation of ovarian follicle atresis. Ann Rev Physiol 1997;59:349-63.
  13. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin 1B, interleukin 6, and vascular endothelial factor. Fertil Steril 1999;71:482-9.
  14. Human oviductal gonadotrophin-releasing hormone: possible implications in fertilization, early embryonic development and implantation. J Clin Endocrinol Metabol 2000;85:1377-81.
  15. The menopausal transition: endocrinological and epidemiological considerations. J Biosoc Sci Suppl 1979;6:19-35.
  16. Fallo ovarico prematuro. In Cabero L and Cabrillo E (Eds): Tratado de Ginecologia, Obstetricia y Medicina de la Reproduccion. Editorial Panamericana, Madrid, 2003, Vol II pp 1344-50.
  17. Evidence for a genetic factor in the etiology of premature ovarian failure. Fertil Steril 1983;40:693-5.
  18. Incidence of premature ovarian failure. Obstet Gynecol 1986;67:604-6.
  19. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997;18:107-34.
  20. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency. Fertil Steril 1991;55:970-5
  21. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab 1988;67:1190-4.
  22. Follicle-stimulating hormone levels in cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-4.
  23. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-91.
  24. The gonadotropin-releasing hormone agonist stimulation test: a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 1991;56:711-7.
  25. Age-specific FSH levels as a tool for appropriate patient counseling in assisted reproduction. Human Reprod 2005;20:2249-52.
  26. Future in vitro fertilization pregnancy potential of women with variable elevated day 3 follicle-stimulating hormone levels. Fertil Steril 1996;65:1238-40.
  27. The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women. Human Reprod 1994;9:245-52.
  28. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reprod Update 2003;9:61-76.
  29. An elevated day 3 FSH/LH ratio in the presence of normal day 3 FSH predicts a poor response to COH. Fertil Steril 1996;65:588-93.
  30. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991-4.
  31. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Human Reprod 1999;14:409-15.
  32. Decreased inhibin tone and increased activin A secretion characterize reproductive aging in women. Fertil Steril 1999;71:658-62.
  33. Dimeric inhibin: a direct marker of ovarian aging. Fertil Steril 1998;70:119-23.
  34. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before rise in follicle-stimulating hormone. Fertil Steril 1999;72:63-5.
  35. Women with poor response to IVF have lower circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles. Human Reprod 2002;17:634-40.
  36. Insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 concentrations in fluid from human stimulated follicles. Human Reprod 1998;13:285-9.
  37. Anti-Mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-62.
  38. Anti-Mullerian hormone and folliculogenesis. Moll Cell Endocrinol 2005;234:81-6.
  39. Prognostic assessment of female fecundity. Lancet 1987;332:645-7.
  40. Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotrophin-stimulated cycles for in vitro fertilization. Human Reprod 1989;6:647-50.
  41. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated hormone levels. Fertil Steril 1992;57:819-624.
  42. Prediction of individual response to controlled ovarian hyperstimulation by means of clomiphene citrate challenge test. Fertil Steril 1990;53:295-301.
  43. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol 1993;82:539-45.
  44. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1-11.
  45. Accuracy of ovarian reserve tests. Human Reprod 1999;14:2822-6.
  46. The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization. Fertil Steril 1991;65:796-9.
  47. Exogenous follicle-stimulating hormone ovarian reserve test (EFFORT): a simple and reliable screening test for detecting Apoor responders@ in in vitro fertilization. Human Reprod 1994;9:1607-11.
  48. Ovarian reserve test with human menopausal gonadotropin as a predictor of in vitro fertilization outcome. J Assisted Reprod Genet 2000;17:13-9.
  49. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography. Fertil Steril 1998;78:671-5.
  50. Polycystic ovarian syndrome: assessment with color Doppler angiography and three-dimensional ultrasonography. J Ultrasound Med 1999;18:303-13.
  51. Ecografia vaginal, Doppler y tridimension en Obstetricia y Ginecologia. Panamericana Edit. Madrid, 2000.
  52. 4D ultrasound in obstetrics and gynecology. Panamericana Edit. Madrid, 2006.
  53. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotrophin. Human Reprod 1997;12:294-7.
  54. Fertil Steril 1995;64:1167-71.
  55. Ovarian volume may predict assisted reproductive outcomes better than follicle-stimulating hormone concentrations on day 3. Human Reprod 1999;14:1752-6.
  56. Managing and predicting low response to standard in vitro fertilization therapy: a review of the options. Mol Cell Endocrinol 2005;234:81-6.
  57. Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level. Fertil Steril 2005;. Fertil Steril 2005; 83;291-301.
  58. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in vitro fertilization. Human Reprod 1997;12:220-3.
  59. Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil Steril 1998;69:505-10.
  60. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve. Fertil Steril 2002;77:328-36.
  61. Age and ovarian follicle pool assessed with transvaginal ultrasonography. Am J Obstet Gynecol 1996;174:624-7.
  62. Antral follicle counts by transvaginal sonography are related to age in women with proven natural fertility. Fertil Steril 1999;72:845-51.
  63. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment. Fertil Steril 1999;71:22-9.
  64. Intraobserver and interobserver reproducibility of ovarian volume, antral follicle count, and vascularity indices obtained with transvaginal 3-dimensional ultrasonography, power Doppler angiography and the virtual organ computer-aided analysis imaging program. J Ultrasound Med 2005;24:1279-87.
  65. The interobserver reliability of ovarian volume measurement is improved with three-dimensional ultrasound, but dependent upon technique. Ultrasound Med Biol 2003;29:1685-90.
  66. Quantitative transvaginal two-and three-dimensional sonography of the ovaries: reproducibility of antral follicle counts. Ultrasound Obstet Gynecol 2002;20:270-5.
  67. A donde vamos en ultrasonidos? Un esfuerzo para ver la vida intrautero mas claramente. Prog Obstet Ginecol 2006;49 (accepted, in press).
  68. Three-dimensional multi-slice view: new prospects for evaluation of congenital anomalies of the fetus. J Ultrasound Med 2006;25:1041-50.
  69. Assesment of ovarian reserve using the inversion mode. Picture of the month. Ultrasound Obstet Gynecol 2006;27:104-6.
  70. Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1997;104:521-7.
  71. Is there a link between an extremely poor response to ovarian hyperstimulation and early ovarian failure? Human Reprod 2002;17:1106-11.
  72. Women with regular menstrual cycles and a poor response in ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril 2002;78:291-7.
  73. A low number of retrieved oocytes at in vitro fertilization treatment is predictive of early menopause. Fertil Steril 2002;77:978-85.
  74. HMG/HCG follicular maturation for oocyte aspiration: phase II, 1981. Fertil Steril 1983;39:174-9.
  75. Clinical histologic correlation in reproductive biology. Obstet Gynecol 2000;95:83 (S).
  76. F. Recombinant follicle-stimulating hormone stimulation in poor responders with normal basal concentrations of follicle-stimulating hormone and estradiol: improved reproductive outcome. Human Reprod 1999; 14:1431-4.
  77. Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal FSH levels. Human Reprod 1994;9:906-11.
  78. Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Human Reprod 1997b; 12:1028-31.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.